The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Oncogenic EGFR Signaling Networks in Glioma
Abstract
EGFR and downstream signaling networks contribute to the hallmark characteristics of glioma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
A Road Map for Those Who Don't Know JAK-STAT
Aaronson, D. S., & Horvath, C. M. (2002) · Science · doi:10.1126/science.1071545 · Cited by 1,337
Genetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Bcl-2 family proteins and cancer
Yip, K. W., & Reed, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.307 · Cited by 881
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Next-Generation Sequencing: From Basic Research to Diagnostics
Voelkerding, K. V., Dames, S. A., & Durtschi, J. D. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112789 · Cited by 839
Wells, A. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00015-1 · Cited by 817
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization
Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H.-S., Leahy, D. J., & Lemmon, M. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00047-9 · Cited by 801
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Phosphotyrosine interactome of the ErbB‐receptor kinase family
Schulze, W. X., Deng, L., & Mann, M. (2005) · Molecular Systems Biology · doi:10.1038/msb4100012 · Cited by 753
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 740
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
A quantitative protein interaction network for the ErbB receptors using protein microarrays
Jones, R. B., Gordus, A., Krall, J. A., & MacBeath, G. (2006) · Nature · doi:10.1038/nature04177 · Cited by 727
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Pauletti, G., Dandekar, S., Rong, H., Ramos, L., Peng, H., Seshadri, R., & Slamon, D. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3651 · Cited by 670
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Alessi, D. R., Barry Caudwell, F., Andjelkovic, M., Hemmings, B. A., & Cohen, P. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01370-1 · Cited by 628
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Huang, H.-J. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X.-D., Huang, C.-M., Gill, G. N., Wiley, H. S., & Cavenee, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2927 · Cited by 595
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors
Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W. Y., & Dikic, I. (2002) · Nature · doi:10.1038/416183a · Cited by 582
van den Bent, M. J., Brandes, A. A., Rampling, R., Kouwenhoven, M. C. M., Kros, J. M., Carpentier, A. F., Clement, P. M., Frenay, M., Campone, M., Baurain, J.-F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5984 · Cited by 575
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
A module of negative feedback regulators defines growth factor signaling
Amit, I., Citri, A., Shay, T., Lu, Y., Katz, M., Zhang, F., Tarcic, G., Siwak, D., Lahad, J., Jacob-Hirsch, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1987 · Cited by 488
Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether
Cho, H.-S., & Leahy, D. J. (2002) · Science · doi:10.1126/science.1074611 · Cited by 447
Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research
Madhavan, S., Zenklusen, J.-C., Kotliarov, Y., Sahni, H., Fine, H. A., & Buetow, K. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0435 · Cited by 423
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
The EGF receptor family: spearheading a merger of signaling and therapeutics
Bublil, E. M., & Yarden, Y. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.008 · Cited by 397
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.74 · Cited by 391
Huang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705158104 · Cited by 390
Self-citationTargeting the protein kinase C family: are we there yet?
Mackay, H. J., & Twelves, C. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2168 · Cited by 373
Lee, J. C., Vivanco, I., Beroukhim, R., Huang, J. H. Y., Feng, W. L., DeBiasi, R. M., Yoshimoto, K., King, J. C., Nghiemphu, P., Yuza, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030485 · Cited by 367
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
de la Iglesia, N., Konopka, G., Puram, S. V., Chan, J. A., Bachoo, R. M., You, M. J., Levy, D. E., DePinho, R. A., & Bonni, A. (2008) · Genes & Development · doi:10.1101/gad.1606508 · Cited by 336
Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.200 · Cited by 305
Integration of EGFR inhibitors with radiochemotherapy
Nyati, M. K., Morgan, M. A., Feng, F. Y., & Lawrence, T. S. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1953 · Cited by 304
Mechanisms for oncogenic activation of the epidermal growth factor receptor
Zandi, R., Larsen, A. B., Andersen, P., Stockhausen, M.-T., & Poulsen, H. S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.06.023 · Cited by 303
Dawson, J. P., Berger, M. B., Lin, C.-C., Schlessinger, J., Lemmon, M. A., & Ferguson, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7734-7742.2005 · Cited by 297
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
de Palazzo, I. G., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., & Weiner, L. M. (1993) · PubMed · Cited by 269
(2003) · PubMed · Cited by 269
Ji, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A., Jung, B. L., McNamara, K., Xia, H., Glatt, K. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510284103 · Cited by 257
Development of novel targeted therapies in the treatment of malignant glioma
Rich, J. N., & Bigner, D. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1380 · Cited by 247
Effects of HER2 overexpression on cell signaling networks governing proliferation and migration
Wolf‐Yadlin, A., Kumar, N., Zhang, Y., Hautaniemi, S., Zaman, M., Kim, H., Grantcharova, V., Lauffenburger, D. A., & White, F. M. (2006) · Molecular Systems Biology · doi:10.1038/msb4100094 · Cited by 247
Self-citationWang, M. Y., Lu, K. V., Zhu, S., Dia, E. Q., Vivanco, I., Shackleford, G. M., Cavenee, W. K., Mellinghoff, I. K., Cloughesy, T. F., Sawyers, C. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4392 · Cited by 240
Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
Birtwistle, M. R., Hatakeyama, M., Yumoto, N., Ogunnaike, B. A., Hoek, J. B., & Kholodenko, B. N. (2007) · Molecular Systems Biology · doi:10.1038/msb4100188 · Cited by 234
Cadieux, B., Ching, T.-T., VandenBerg, S. R., & Costello, J. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1547 · Cited by 234
Du, J., Bernasconi, P., Clauser, K. R., Mani, D. R., Finn, S. P., Beroukhim, R., Burns, M., Julian, B., Peng, X. P., Hieronymus, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1513 · Cited by 232
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
Zhu, H., Acquaviva, J., Ramachandran, P., Boskovitz, A., Woolfenden, S., Pfannl, R., Bronson, R. T., Chen, J. W., Weissleder, R., Housman, D. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813314106 · Cited by 231
Feldkamp, M. M., Feldkamp, M. M., Lala, P., Lau, N., Roncari, L., Guha, A., Guha, A., & Guha, A. (1999) · Neurosurgery · doi:10.1097/00006123-199912000-00034 · Cited by 227
Scott, A. M., Lee, F.-T., Tebbutt, N., Herbertson, R., Gill, S. S., Liu, Z., Skrinos, E., Murone, C., Saunder, T. H., Chappell, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611693104 · Cited by 222
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 221
Maher, E. A., Brennan, C., Wen, P. Y., Durso, L., Ligon, K. L., Richardson, A., Khatry, D., Feng, B., Sinha, R., Louis, D. N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2072 · Cited by 210
Thiessen, B., Stewart, C., Tsao, M., Kamel-Reid, S., Schaiquevich, P., Mason, W., Easaw, J., Belanger, K., Forsyth, P., McIntosh, L., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1041-6 · Cited by 209
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.
Moscatello, D. K., Montgomery, B., Sundareshan, P., McDanel, H. J., Wong, M. Y., & Wong, A. J. (1996) · PubMed · Cited by 207
Mishima, K., Johns, T. G., Luwor, R. B., Scott, A. M., Stockert, E., Jungbluth, A. A., Ji, X.-D., Suvarna, P., Voland, J. R., Old, L. J., et al. (2001) · PubMed · Cited by 204
Lessons learned in the development of targeted therapy for malignant gliomas
Omuro, A. M. P., Faivre, S., & Raymond, E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0047 · Cited by 196
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
Bouyain, S., Longo, P. A., Li, S., Ferguson, K. M., & Leahy, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507591102 · Cited by 192
Fan, Q.-W., Cheng, C. K., Nicolaides, T. P., Hackett, C. S., Knight, Z. A., Shokat, K. M., & Weiss, W. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2154 · Cited by 192
Common effector processing mediates cell-specific responses to stimuli
Miller-Jensen, K., Janes, K. A., Brugge, J. S., & Lauffenburger, D. A. (2007) · Nature · doi:10.1038/nature06001 · Cited by 191
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Sampson, J. H., Crotty, L. E., Lee, S., Archer, G. E., Ashley, D. M., Wikstrand, C. J., Hale, L. P., Small, C., Dranoff, G., Friedman, A. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130166597 · Cited by 188
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Fan, Q.-W., Cheng, C., Knight, Z. A., Haas-Kogan, D., Stokoe, D., James, C. D., McCormick, F., Shokat, K. M., & Weiss, W. A. (2009) · Science Signaling · doi:10.1126/scisignal.2000014 · Cited by 186
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
From Tpr-Met to Met, tumorigenesis and tubes
Peschard, P., & Park, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210201 · Cited by 180
EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes
Grandal, M. V., Zandi, R., Pedersen, M. W., Willumsen, B. M., van Deurs, B., & Poulsen, H. S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm058 · Cited by 179
Prigent, S. A., Nagane, M., Lin, H., Huvar, I., Boss, G. R., Feramisco, J. R., Cavenee, W. K., & Huang, H.-J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25639 · Cited by 175
Learn, C. A., Hartzell, T. L., Wikstrand, C. J., Archer, G. E., Rich, J. N., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0521 · Cited by 173
Signalling shortcuts: cell-surface receptors in the nucleus?
Wells, A. H., & Marti, U. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm905 · Cited by 172
Mechanisms controlling EGF receptor endocytosis and degradation
Dikic, I. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311178 · Cited by 167
Verbeek, B. S., Adriaansen-slot, S. S., Feltkamp‐Vroom, T. M., Beckers, T. L., & Rijksen, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00224-5 · Cited by 167
Kodama, T., Ikeda, E., Okada, A., Ohtsuka, T., Shimoda, M., Shiomi, T., Yoshida, K., Nakada, M., Ohuchi, E., & Okada, Y. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63429-3 · Cited by 165
Schmidt, M. H. H., Furnari, F. B., Cavenee, W. K., & Bögler, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031790100 · Cited by 164
Shao, H., Cheng, H. Y., Cook, R. G., & Tweardy, D. J. (2003) · PubMed · Cited by 158
Actin microfilament aggregation induced by withaferin A is mediated by annexin II
Falsey, R. R., Marron, M. T., Gunaherath, G. M. K. B., Shirahatti, N. V., Mahadevan, D., Gunatilaka, A. A. L., & Whitesell, L. J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio755 · Cited by 149
PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors
Mellinghoff, I. K., Cloughesy, T. F., & Mischel, P. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1992 · Cited by 146
Ramnarain, D. B., Park, S., Lee, D. Y., Hatanpaa, K. J., Scoggin, S. O., Otu, H., Libermann, T. A., Raisanen, J. M., Ashfaq, R., Wong, E. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2753 · Cited by 140
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells
Turnert, T., Chen, P., Goodly, L. J., & Wells, A. H. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00123400 · Cited by 139
Ding, H., Shannon, P. T., Lau, N. C., Wu, X., Roncari, L., Baldwin, R. L., Takebayashi, H., Nagy, A., Gutmann, D. H., & Guha, A. (2003) · PubMed · Cited by 135
Liu, F., Park, P. J., Lai, W. R., Maher, E. A., Chakravarti, A., Durso, L. E., Jiang, X., Yu, Y., Brosius, A., Thomas, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1408 · Cited by 115
On the nature of low- and high-affinity EGF receptors on living cells
Özcan, F., Klein, P., Lemmon, M. A., Lax, I., & Schlessinger, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601469103 · Cited by 112
Johns, T. G., Luwor, R. B., Murone, C., Walker, F., Weinstock, J., Vitali, A. A., Perera, R. M., Jungbluth, A. A., Stockert, E., Old, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036503100 · Cited by 107
EGF receptor amplification and expression in human brain tumours
Chaffanet, M., Chauvin, C., Lainé, M. G., Berger, F. R., Chedin, M., Rost, N., Nissou, M.-F., & Benabid, A. L. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90374-b · Cited by 104
Perera, R. M., Narita, Y., Furnari, F. B., Gan, H. K., Murone, C., Ahlkvist, M., Luwor, R. B., Burgess, A. W., Stockert, E., Jungbluth, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2653 · Cited by 103
Humphrey, P. A., Gangarosa, L. M., Wong, A. J., Archer, G. E., Lund‐Johansen, M., Bjerkvig, R., Laerum, O.-D., Friedman, H. S., & Bigner, D. D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91051-d · Cited by 99
Montgomery, B., Moscatello, D. K., Wong, A. J., Cooper, J. A., & Stahl, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30562 · Cited by 87
Martens, T., Laabs, Y., Günther, H. S., Kemming, D., Zhu, Z., Witte, L., Hagel, C., Westphal, M., & Lamszus, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0147 · Cited by 87
Pedersen, M. W., Tkach, V., Pedersen, N. M., Berezin, V., & Poulsen, H. S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11566 · Cited by 85
Hendriks, B. S., Orr, G., Wells, A. H., Wiley, H. S., & Lauffenburger, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410491200 · Cited by 84
Johns, T. G., Mellman, I., Cartwright, G. A., Ritter, G., Old, L. J., Burgess, A. W., & Scott, A. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-1766fje · Cited by 83
Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII
Han, W., Zhang, T., Yu, H. W., Foulke, J. G., & Tang, C. K. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3226 · Cited by 77
Frederick, L. A., Eley, G. D., Wang, X.-Y., & James, C. D. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.159 · Cited by 76
Hong, C., Moorefield, K. S., Jun, P., Aldape, K., Kharbanda, S., PHILLIPS, H. S., & Costello, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700683104 · Cited by 73
Uncovering Therapeutic Targets FOR Glioblastoma: A Systems Biology Approach
Huang, P. H., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4922 · Cited by 72
Self-citationModeling the Effects of HER/ErbB1-3 Coexpression on Receptor Dimerization and Biological Response
Shankaran, H., Wiley, H. S., & Resat, H. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.080580 · Cited by 72
Joughin, B. A., Naegle, K. M., Huang, P. H., Yaffe, M. B., Lauffenburger, D. A., & White, F. M. (2008) · Molecular BioSystems · doi:10.1039/b815075c · Cited by 36
Self-citationEGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins
Davies, G., Ryan, P. E., Rahman, L., Zajac‐Kaye, M., & Lipkowitz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209662 · Cited by 34
Cited by
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
Li, X., Wu, C., Chen, N., Gu, H., Yen, A., Cao, L., Wang, E., & Wang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7961 · Cited by 542
Roles for Growth Factors in Cancer Progression
Witsch, E., Sela, M., & Yarden, Y. (2010) · Physiology · doi:10.1152/physiol.00045.2009 · Cited by 526
Glioblastoma: From Molecular Pathology to Targeted Treatment
Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130324 · Cited by 518
Metadata
- Authors
- Huang, P. H., Xu, A. M., & White, F. M.
- Venue
- Science Signaling
- Published
- 2009-09-08
- Volume
- 2
- Issue
- 87
- Pages
- re6-re6
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2136734008
- Cited by
- 363
- References
- 114
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.